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                                                                                   Abstract 
Background:   Patient-controlled analgesia (PCA) administration of opioids is associated with 
risk for respiratory depression. Capnography is a non-invasive way to identify early respiratory 
depression and prevent adverse patient events.  
Purpose: This project evaluated the effectiveness of capnography versus standard monitoring in 
reducing adverse events among patients admitted to an intensive care unit (ICU) who were 
prescribed PCA opioids and evaluated patients at high-risk for respiratory depression according 
to age, gender, diagnosis, co-morbidities, and type of opioid prescribed. 
Methods:   This project used a pre- and post-intervention design to compare differences in the 
number of adverse events among 20 adult patients admitted to an ICU during a six-month period 
who were prescribed PCA opioids and received either capnography monitoring or standard 
monitoring.  A chi-square test was conducted to evaluate group differences. 
Results:  The number of adverse events was not significantly different between patients who 
received standard monitoring versus those who received capnography (X2=0.00, df=1, N=20, 
p>0.05). Adverse events were not significantly associated with age, gender, number of co-
morbidities, type of opioid, and diagnosis (p>0.05). 
Conclusions: Implementation of capnography among ICU patients on PCAs did not decrease the 
number of adverse events. However, there were favorable trends noted with regards to sedation 
level and a decrease in the occurrence of bradypnea in patients receiving capnography.  Results 
from this project will guide the implementation of capnography throughout the institution.  
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                                                       Introduction 
     Opioids used for pain control are recognized to be a main factor for respiratory depression 
(The Joint Commission, 2012) and account for a rising number of patient deaths in hospitals.  
This has raised alarm from both The Joint Commission (TJC) (2019) and the Institute for Safe 
Medication Practices (ISMP) (2009, 2013).  The risk for respiratory depression increases with 
the use of patient-controlled analgesia (PCA) and frequent administration of high doses of 
opioids without PCA (ISMP, 2013). This increased mortality results from failure to recognize 
some patients at high risk for respiratory depression with opioid administration and lack of close 
monitoring of these same patients.   
Professional organizations suggest institutions define patient characteristics that are 
associated with a high-risk for respiratory depression based on their community’s population 
(American Society of Anesthesiologists (ASA), 2018; Jarzyna, et. al., 2011). These same 
organizations, as well as TJC and ISMP, encourage hospitals to develop policies and procedures 
for monitoring all patients receiving opioids, particularly those at high-risk for respiratory 
depression, and to use technology to assist with monitoring.  Capnography detects early 
respiratory failure and is a sensitive tool for identifying respiratory depression before vital sign 
and sedation level deterioration.   
      This evidenced-based practice (EBP) project compared capnography monitoring versus 
standard monitoring among patients prescribed epidural or intravenous (IV) PCAs or high doses 
of opioids and evaluated the number and type of adverse events including rates of hypercapnia 
and/or hypoxia, hypotension, sedation level, and bradypnea. This project also evaluated the 
impact of age, gender, diagnosis, type of opioid prescribed, and number of co-morbidities on the 
number of adverse events to identify patient characteristics associated with a high risk for 
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respiratory depression and define criteria for capnography monitoring.  The project informed the 
development of criteria for capnography monitoring for patients receiving opioids at an academic 
research hospital and provided evidence to guide the development of policies, procedures, and 
education for nursing and medical professionals when capnography is implemented throughout 
the hospital.     
                                                              Significance                                                                                                              
     The risk of death from respiratory depression due to opioid therapy increases with the use of 
patient-controlled analgesia (PCAs). In 2008, an analysis of 500 hospitals revealed that 6.5% of 
PCA errors caused patient harm, as compared with 1.5% general medication errors (Hicks, 
Sikirica, Nelson, Schein, Cousins, 2008). In a retrospective review of national, multi-
institutional post-operative opioid overdose, Cauley, et. al. (2017) described that the frequency of 
overdose doubled from 0.6 to 1.1 per 1000 cases from 2002 to 2011. The authors concluded that 
recognition of patients who were at high risk for overdose and implementation of proper 
monitoring should be employed to prevent fatalities. In 2012, TJC issued a sentinel alert advising 
hospitals to implement policies for the early assessment of opioid induced respiratory depression. 
The Joint Commission has no specific monitoring recommendations other than identifying 
patients as high risk and implementing evidenced based guidelines (TJC, 2019). The ISMP 
recommends regular interval monitoring of vital signs, physical assessment, pain and sedation 
assessment, and monitoring of respiratory status using technology (ISMP, 2013). Capnography is 
a sensitive method for measuring ventilation and respiratory rate. It can provide early warning of 
respiratory failure hours before pulse oximetry detects oxygen desaturation (Burton, Harrah, 
Germann, & Dillion, 2006; Kopka, et. al., 2007). Implementing capnography has the potential to 
detect respiratory deterioration early in order to institute measures to prevent respiratory 
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depression, improve outcomes, and decrease adverse events among patients receiving PCA and 
opioids in the ICU.   
                                                           Background 
   Capnography is a sensitive technology used for identifying normal oxygen exchange. 
Capnography, or end tidal carbon dioxide (ETCO2) monitoring, detects levels of carbon dioxide 
in a person’s blood. Normal ETCO2 levels are between 35-45 mm Hg. High levels of ETCO2 
are called hypercapnia and indicate that the person is retaining carbon dioxide. This happens 
with depressed respiratory rate. Capnography has the advantage of detecting early respiratory 
depression as the ETCO2 will start to rise before the oxygen level in the blood begins to fall 
(Jarzyna, et. al., 2011; Burton, Harrah, Germann, & Dillion, 2006; Kopka, et. al., 2007)  
 In 2017, the Surgeon-in-Chief at the institution where this project was implemented 
requested that capnography be employed as a non-invasive way to identify early respiratory 
depression for patients on both epidural and intravenous patient-controlled analgesia (PCA). The 
current process for monitoring all patients in the ICU consists of continuous vital sign 
monitoring, including pulse oximetry, and sedation level.  Pain and sedation are assessed every 
four hours or more frequently if the patient is not achieving satisfactory pain control or if there 
are rate changes to the PCA or extra doses of opioids administered for those not on a PCA.  
Capnography monitoring is currently not routinely used for patients on PCAs or receiving 
opioids in the ICU. 
     At the same time as the Surgeon-in-Chief’s request, the institution underwent a voluntary 
survey by the ISMP. The ISMP recommended utilizing advanced technology, such as 
capnography, for recognizing early respiratory depression for patients on PCAs. Although vital 
sign and sedation monitoring is crucial, capnography is a more sensitive method to recognize 
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early respiratory depression. Based on both the Surgeon-in-Chief’s’ request and the ISMP 
recommendations, the Oncology Clinical Nurse Specialist was charged with researching best 
practices and tools for detecting early respiratory depression in patients receiving opioids 
through a PCA.   
      It was agreed at the outset of this initiative that it would not be necessary for every patient on 
a PCA or receiving opioids in the hospital to be placed on capnography based on the recognition 
that not all patients would be at high risk for respiratory depression. Therefore, following 
recommendations from professional organizations (ISMP, 2013; ASA, 2018; Jarzyna,et. al., 
2011), defining the characteristics of what makes a patient who is prescribed opioids as “high-
risk” for respiratory depression is of interest to the organization where this project was 
conducted. It was also pointed out by the pediatricians and pediatric nurses that children do not 
tolerate the large nasal cannula used for capnography.  Currently, children at this institution on 
PCAs and receiving high doses of opioids are monitored using continuous pulse oximetry.  
Therefore, children were excluded from this project.  A group of stakeholders met in 2017 to 
determine the criteria which would qualify a patient as high-risk for respiratory depression with 
opioid use and thus require capnography monitoring. The original stakeholder group consisted of 
practitioners from the Pain and Palliative Service, surgeons, physicians, and nurse practitioners 
from service areas outside of surgery, plus Clinical Nurse Specialists and nurses from across the 
hospital. The final criteria developed focused exclusively on dosages of opioids and adjunct 
medications prescribed; patient characteristics such as age and co-morbidities that could also 
qualify a patient as high-risk were assumed left to the discretion of the prescriber or nurse.   
      Based on the work done by the stakeholder group, a pilot project was proposed to implement 
and evaluate capnography monitoring in the ICU before deploying this equipment to the entire 
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hospital. The results of this EBP project will contribute to final policy and procedure development. 
This project added important elements for the development of nursing and practitioner education 
through the experience of the staff in the pilot unit. It identified technological issues that will 
impact delivery of care. With publication of results, the project could help other institutions decide 
if implementation of capnography monitoring would be beneficial for their patient population. 
Needs Assessment 
     A Strengths, Weaknesses, Opportunities and Threats (SWOT) analysis of barriers and 
facilitators for this initiative was conducted (see Appendix A). The implementation of 
capnography monitoring in the ICU for patients at high-risk for respiratory depression from 
opioids had strong support from medical and nursing leadership at the institution. Facilitators 
included a group of stakeholders with expertise in pulmonary medicine and pain management 
among medicine, nursing, respiratory therapy, and pharmacy. Guidance from accrediting 
organizations concerned with patient safety and evidence in the literature also provided 
validation of the need for using technology to improve assessment in patients receiving opioids 
(TJC, 2019; ISMP, 2009, 2013). Capnography has been demonstrated through randomized 
controlled studies to be superior in providing non-invasive monitoring for early respiratory 
depression (Deitch, et. al., 2010; Friedrich-Rust, et. al., 2014; Li, et. al., 2018). New vital sign 
machines with capnography capability have been purchased for units outside of the ICU. End 
tidal carbon dioxide will be able to be monitored outside of the ICU for patients on PCAs or 
receiving high doses of opioids and at risk for respiratory depression.  This has the advantage of 
allowing nurses to perform “softer” interventions such as withholding the narcotic or re-
positioning rather than administration of naloxone or other rescue measures.  Other facilitators 
included a robust nursing shared governance model that is committed to implementing best 
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evidenced based practice in the care of our patients. Nurses newly employed by the Clinical 
Center also bring experience from the community and champion best practices. A strong nursing 
education department and CNS group who are engaged with the nurses can quickly develop 
education plans and competencies to enhance nursing practice of patients receiving opioid or 
narcotic infusions. 
     Barriers included concerns from our cybersecurity department about hacking into informatic 
systems.  The capnography equipment will be wireless, requiring the informatics security 
department to fully test the wireless functionality for breeches interfacing with the medical 
records informatic enterprise.   Other barriers included agreement on the definition of patients 
considered high risk for respiratory depression and based on long tenured practitioners, some 
may not be up to date on current practice. There is also the possibility for resistance to placing 
patients on capnography due to the fear that capnography would interfere with research 
interventions. Continued assurance that this intervention will not interfere with research 
objectives while ensuring ongoing best clinical care of the patient is necessary to prevent 
derailment of this initiative. 
Problem Statement 
     Currently, patients in the ICU on PCAs and opioids are not monitored with capnography. 
Implementing capnography monitoring for ICU patients on PCAs and opioids had the potential 
to decrease the incidence of adverse events and identify patients who would most benefit from 
this level of monitoring.   
     Use of naloxone from January 2019 through May 2020 throughout all units of this institution 
to treat respiratory depression secondary to opioids had been 37 occurrences.  Detection of early 
respiratory depression using capnography allows prescribers and nurses to intervene with less 
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invasive interventions before requiring the administration of naloxone. It allows the nurse to 
perform interventions such as repositioning and/or decreasing or withholding opioid doses before 
administration of naloxone as this antidote is not without adverse effect.  
Purpose Statement 
     The purpose of this project was to evaluate the effectiveness of capnography versus standard 
monitoring to improve outcomes among patients admitted to an intensive care unit (ICU) who 
were prescribed patient-controlled analgesia (PCA) or high doses of opioids and were considered 
at high risk for respiratory depression.    
Aims and Objectives 
               The aims for this project were to:                
1.  Implement capnography monitoring for all ICU patients on PCAs and high doses of 
opioids beginning September 8, 2020 through December 1, 2020.   
2. Conduct a retrospective chart review to create a data set with outcomes for ICU patients 
on PCAs and high dose opioids who received standard monitoring for 3 months prior to 
implementation of capnography.   
3. Compare differences in number of adverse patient events (defined as hypercapnia and/or 
hypoxia, decreased sedation, bradypnea, hypotension) between ICU patients on PCAs or 
high doses of opioids monitored with capnography versus standard monitoring by 
December 31, 2020.  
4. Compare differences in number of episodes of adverse patient events (hypercapnia, 
hypoxia, hypotension, decreased sedation level, bradypnea) as well as variation in age, 
sex, diagnosis, co-morbidities, and type of opioid between ICU patients on PCAs or high 
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dosages of opioids to better define high-risk for respiratory depression versus not high-
risk by December 31, 2020. 
 
 
Objective for this EBP initiative included:  
1. Decrease in adverse respiratory events in adult high-risk patients in the ICU who received 
PCAs or high doses of opioids to zero during the 3-month period after implementation of 
capnography by December 2020. 
2. Analyze data and use project findings to inform the development of policies and 
procedures for capnography monitoring for patients on PCAs or receiving opioids by 
January 2021.  
Literature Review  
          A literature search was conducted on September 10, 2019 to determine if capnography was 
superior at detecting early respiratory depression as opposed to pulse oximetry, a measurement 
of oxygen saturation, in patients receiving moderate sedation and/or opioids.  The literature 
search was conducted with the assistance of one of the research librarians at the institution in 
which this project was implemented. Databases searched were PubMed, Medline, CINAHL, 
Google Scholar, and Web of Science. Terms used for the literature search, which included 
Boolean terms, were “capnography”, “capnography monitoring AND opioids”, “capnography 
AND moderate sedation”, “capnography/or analgesia”, “capnography/or anesthesia” and “end 
tidal CO2”.  MeSH terms for PubMed were applied including “capnography” “analgesia” and 
“monitoring”. Limits for the search included articles no older than 15 years and articles 
published in English or translated into English. The search yielded a total of eight usable articles 
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(Campbell, et. al., 2016; Deitch, Miner, Chudnofsky, Dominici & Latta, 2010; Friedrich-Rust, et. 
al., 2014; Gupta, et. al., 2018; Jarzyna, et. al., 2011; Mehta, et. al., 2016; Li, et. al., 2018; Sites, 
Surprise, McNeil, Northrop & Ruyter, 2017).  (See Appendices B and C) 
      Inclusion criteria for the search included 1) Use of capnography, 2) Adult population greater 
than 18, 3) Moderate sedation or patient controlled analgesia, 4) Articles published in English 5), 
Articles published in the last 15 years, 6) Randomized controlled trials, 7) Position 
statements/Clinical Practice Guidelines from professional organizations, and 8) Systematic 
Reviews.  
     Since capnography is also used in intensive care units and the operating room, exclusion 
criteria included the use of capnography in clinical areas where it is standard of practice. This 
includes 1) Use of capnography in operating rooms, 2) During resuscitative events and 3) During 
intubation or endotracheal tube placement. Also excluded were opinion papers and case reports. 
    All randomized controlled studies but two found monitoring for respiratory compromise with 
capnography technology was superior to other forms of non-invasive monitoring. Several trials 
found that patients who received capnography monitoring, as opposed to continuous pulse 
oximetry, had fewer events of hypoxemia, hypoventilation, and earlier detection of respiratory 
compromise (Deitch, et. al., 2010; Friedrich-Rust, et. al., 2014; Li, et. al., 2018; Stites, et. al., 
2017). A systematic review by Gupta, et. al. (2018) found that monitoring with pulse oximetry 
and capnography, as well as sedation level, resulted in decreased respiratory adverse events for 
patients defined as high-risk. This study identified common factors that put a patient at high-risk 
of respiratory depression. Common factors in the studies that put a patient at higher risk of OIRD 
included preoperative gabapentin or sustained release oxycodone, time from surgery (first 24 
hours after surgery (in PACU), with a predominance in the first 12 hours), age (>60 years), sex 
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(female) and comorbidities such as obstructive sleep apnea, cardiac disease, obesity, two or more 
comorbidities, and opioid dependence.  Professional organizations, including the American 
Society of Anesthesiologists, American Society for Pain Management Nursing and ISMP 
endorse capnography as the most sensitive method for non-invasive monitoring of ventilation.  
      Although capnography is a sensitive method for detecting impaired ventilation, two of the 
randomized controlled trials found that frequent monitoring of sedation level, pulse oximetry, 
and vital signs was as effective as capnography in obtaining safe outcomes for the patient.  The 
studies by Campbell et. al. (2016) and Mehta, et. Al., (2016) were randomized controlled trials 
that enrolled patients older than 16 years of age undergoing procedural sedation.  The researchers 
found no differences in clinical outcomes between those receiving frequent monitoring versus 
those patients receiving capnography. Though capnography detected hypoxia earlier than pulse 
oximetry alone, the researchers concluded that frequent monitoring of sedation, vital signs and 
pulse oximetry was as effective as capnography monitoring.  
     Conversely, other studies found added value when capnography was utilized during moderate 
sedation. Dietch, et. al. (2010) found a 15% decrease in the incidence of hypoxia with use of 
capnography versus standard monitoring in participants who were receiving propofol in an 
emergency department.  Friedrich-Rust, et. al., (2014) found parallel results when using propofol 
for patients undergoing colonoscopy or colonoscopy plus endoscopy. Patients in the 
capnography group experienced fewer episodes of hypoxemia (18% vs. 32%).   Li, et. al. (2018) 
studied women who were receiving propofol while undergoing lumpectomy. This study 
replicated the above studies in that the control group received standard monitoring plus ETCO2 
monitoring that could be visualized by the provider. The researchers found that CO2 retention 
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was lower in the control group, episodes of apnea occurred less frequently in the control group, 
and women who had ETCO2 monitoring had shorter recovery times.  
      Use of capnography allows nurses to intervene early on recognition of opioid induced 
respiratory depression.  Stites, et. al., (2017) studied nurses’ recognition of increased CO2 levels 
and actions taken to correct impending respiratory distress. This study looked at the number of 
rapid response calls (RRT) for opioid induced respiratory depression in patients who received 
opioids through a PCA before and after hospital wide implementation of capnography for all 
patients on PCAs. They found that the number of RRTs decreased after implementation of 
capnography (0.04% pre-intervention vs. 0.02% post-intervention) indicating that nurses were 
identifying opioid induced respiratory depression early.  
       Many studies support the use of capnography as a sensitive way to monitor for early 
respiratory depression.  A systematic review by Gupta, et. al. (2018) was conducted that 
summarized risk factors of opioid induced respiratory depression in the postoperative period and 
monitoring interventions that decreased adverse events. The review comprised 13 studies with 
871,912 surgical patients. Monitoring of sedation level, pulse oximetry and capnography in 
patients at risk of opioid induced respiratory depression (OIRD) decreased adverse respiratory 
events. The authors recommended that monitoring ETCO2 and oxygen saturation coupled with 
assessment of risk factors listed above will decrease adverse events in post-operative patients. 
    Finally, the American Society of Pain Management Nursing (ASPMN) agrees with the ISMP, 
The Joint Commission, American Society of Anesthesiologists (2018), and other agencies 
concerned with patient safety that capnography can provide early detection of respiratory 
compromise in a high-risk patient thus allowing nurses to intervene before cardiac arrest 
(Jarzyna, et.al., 2011).  Their published position statement was based on extensive review of the 
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literature, external peer review of applicability, and accuracy of the literature. Based on review 
of the literature, risk factors of OIRD are divided into four categories: Individual risk, iatrogenic 
risk, pharmacology, and monitoring capabilities. The ASPMN acknowledges that the cost of 
capnography equipment, diverse patient populations, training of nursing staff, and non-consensus 
of monitoring frequency are challenges when interpreting guidelines.  
                                            Evidenced Based Translation Model 
     The model that was selected for this project was the Rosswurm and Larrabee model 
(Rosswurm & Larrabee, 1999).   The purpose of this model is to integrate evidenced based 
practice into care and move away from traditional practice models. The model consists of six 
steps:  Assess the need for change, link outcomes, synthesize the evidence, design the practice 
change, implement, and integrate and maintain (see Appendix D). This model mirrors the 
practice of a Clinical Nurse Specialist (CNS).  It is a linear model that allows for in-depth 
analysis at each step. The details surrounding this model for the project include: 
1. Assess need for change in practice:  The need for more sensitive monitoring for patients 
on PCAs and receiving escalating doses of opioids had been identified.  A group of 
stakeholders from different specialty areas met. Data regarding adverse events was 
reviewed at the initial meeting and the need for improvement in our practice was 
identified. 
2. Link outcomes:  Outcomes for the implementation of capnography monitoring were 
identified.  Rapid response calls and events surrounding respiratory depression with 
opioids (naloxone use) in the post-anesthesia care unit were discussed.  Though the 
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history of adverse events has been low for patients on PCAs, these events were discussed 
with the goal towards avoiding future events.   
3. Synthesize evidence:  A literature search was conducted.  At issue in the literature was 
the need for defining the “high risk” patient who would benefit from capnography.  Over 
30 definitions of “high risk” were discovered in the literature.  Including all these 
definitions was neither feasible nor realistic for our population.  
4. Design the practice change:  In light of all the definitions, the stakeholder group re-
convened and decided on the definition of “high risk” for the population that we see at 
the NIH.  
5. Implementation:  This pilot project was conducted in preparation for implementation to 
the rest of the hospital. Nursing policy was updated and education was planned while 
awaiting final details on arrival and installation of the equipment.  Order sets and a 
medical policy were developed. A final definition of high-risk will be decided upon after 
review of the findings from this pilot project. Flow sheets will be revised in the future so 
that nurses have a place to document capnography monitoring.  
6. Integrate and Maintain:  Policy and procedures will either need to be created or revised 
once this project is implemented hospital wide..  Whether this change will be integrated 
into existing nursing policy on non-invasive ventilation, or a medical policy created or 
revised will need to be decided upon by nursing and medical leadership.  Staff education 
will need to be developed as well.  Ongoing, implementation of this new process will 
need to be evaluated to include patients defined as high-risk, nursing and licensed 
independent practitioner ongoing education and competency validation, and identification 
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of equipment issues such as, the number of false alarms. Process and clinical outcome 
measures will need to be developed to assure that new technology and criteria are being 
used appropriately, and clinical outcomes demonstrate improvement.  Documentation 
standards and practices will need to be evaluated for consistency.  
                                                                Methodology  
     This EBP project implemented and evaluated the effectiveness of capnography versus 
standard monitoring for improving outcomes among adult ICU patients (defined as aged 18 years 
or older) on PCAs or receiving opioids. The project design was a pre-and post-intervention 
comparison of outcomes for ICU patients on PCAs who received standard monitoring over a 
three-month period compared with those patients who received capnography monitoring for a 3-
month period. During implementation of the project, all patients on IV or epidural PCA or those 
not on PCA but meeting high risk criteria (use of two or more pain control or adjunct agents 
simultaneously or frequent escalating doses of oral or IV intermittent narcotics) were placed on 
capnography. 
     Data was entered into the Statistical Package for Social Sciences (SPSS) software for data 
analysis.  The final sample size was 20 patients: 10 patients in the “Retrospective” sample 
(hereafter referred to as the “standard monitoring group”) and 10 patients in the 
“Implementation” (referred to as the “capnography group”) sample.  The spreadsheet was sent to 
the primary and secondary project advisors, for review of data accuracy.  There were no outliers 
or missing data.   
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Setting 
     The setting for this project was a 12-bed ICU in an academic research hospital in the Mid-
Atlantic region.  This ICU is the only ICU in the hospital and admits medical and surgical 
patients, including pediatrics.  
     The ICU has capnography equipment installed and the nurses are experts at interpreting 
capnography as part of standard critical care competency. Capnography is currently not used 
routinely on ICU patients who are administered opioids or prescribed PCAs. This form of 
monitoring is typically only used post-resuscitation for up to 24 hours.  
Participants 
    Eligibility criteria for inclusion in this project for both the standard monitoring and 
capnography groups included adult patients over the age of 18 who were prescribed either an IV 
or epidural PCA or opioids administered by another route. Exclusion criteria included those who 
received sedation due to critical illness and patients who received end of life care. Patients who 
received sedation due to intubation or critical illness were excluded as they were too critically ill 
to differentiate if adverse events were due to the opioids or illness. 
Recruitment 
  The sample for this project was a convenience sample of patients admitted to the ICU during 
the project period who met eligibility criteria.  
Risk/Harms 
     Risk with using capnography is minimal. The nasal cannula is larger than an oxygen cannula 
so it can be uncomfortable. This can prompt a patient to remove it. Also, cannulas can cause 
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pressure injury to the ears and nose. Like an oxygen cannula, nurses assessed for pressure 
injuries caused by devices as part of regular assessment.    
Cost and Compensation 
     Budget requirements were non-existent. Capnography equipment is already installed in the 
ICU.  The ICU nurse educator and CNS provided support for this project and were able to 
provide ongoing assistance with education of capnography monitoring. The project did not 
require extra staff support for implementation. Patients were not compensated for their 
participation.  
Interventions 
Standard Monitoring Group:  A retrospective chart review was conducted to identify all ICU 
patients prescribed PCAs or opioids three months before implementation of capnography from 
June through August 2020. These ICU patients received standard monitoring.  Standard 
monitoring consisted of continuous vital sign monitoring including continuous pulse oximetry, 
pain assessment every four hours, and continuous sedation assessment.  Capnography in the ICU 
during this time period was only used for post-resuscitative events for approximately 24 hours; it 
was not routinely used for patients receiving PCAs or opioids.  Data collection from these 
patients includes the variables listed in Appendix E.                                            
Capnography Group:  Before the implementation phase of the project began, a meeting was 
called with the medical, nursing, pharmacy, and respiratory staff to describe the project. All 
patients admitted to the ICU for three months of the intervention period, September through 
December 8, 2020, on IV or epidural PCAs or those meeting high risk criteria not on PCA (use 
of two or more pain control or adjunct agents simultaneously or frequent escalating doses of oral 
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or IV intermittent narcotics) were placed on capnography (Appendix F). In addition to the 
capnography monitoring, all patients received standard monitoring as described above.    
        Monitoring equipment utilized in the ICU is the Philips MX800 critical care monitor. This 
monitor consists of a bedside monitor next to each ICU bed, central monitors at the nursing 
station and monitors at regular intervals along the upper wall in the hallway (4 hallway 
monitors). Visualization of all patients can occur anywhere in the ICU main and overflow areas 
(except the break room, conference room, bathroom, or offices). The central monitor can 
accommodate up to 12 patients. The equipment measures pulse, respiratory rate, blood pressure, 
oxygen saturation, and mean arterial pressure with waveforms through the arterial line. For 
patients without an arterial line and for emergencies in case the arterial line is not functioning 
well, a blood pressure cuff is placed on the patient and inflated at intervals determined by the 
nurse and physician to measure blood pressure, pulse, and mean arterial pressure. Oxygen 
sensors can be placed on fingers, toes, or ears to capture oxygen saturation for those without an 
arterial line. The monitors record cardiac rhythm through a five-lead electrocardiogram 
monitoring system. End tidal carbon dioxide (ETCO2) is measured through a nasal cannula 
designed for ETCO2 measurements. This cannula connects into the monitoring equipment at the 
bedside to capture values. All patient measurements are continuously recorded and electronically 
interfaced with the critical care medical record at hourly intervals.  All monitors automatically 
default to the normal value of ETCO2 35-45mmHg and for the purposes of this project, the 
normal ETCO2 values of 35-45mmHg were utilized.   
Outcomes Measured 
          Outcomes measured included the number and type of adverse events defined as 
hypercapnia (if on capnography), hypotension, hypoxia, sedation level, and bradypnea.  
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Hypercapnia was defined as an ETCO2 greater than 45mmHg.  Hypotension was defined as a 
blood pressure <90/60.  Hypoxia was defined as an oxygen saturation less than 90 percent.  
Respiratory rate that was considered an indication of respiratory depression is less than 12 
breaths per minute.  Sedation level was monitored using the sedation scale associated with the 
institution’s pain scale ranging from alert and oriented to hallucinating/confused to unarousable 
(see Appendix E).  
           Measurement of pain utilized the Numeric Pain Rating Scale (McCaffery & Beebe, 1993). 
This pain scale is a validated pain scale that is widely used throughout the United States. Patients 
rate their pain from 0 (no pain) to 10 (worst pain). Pain and sedation level were assessed by the 
nurses every four hours and recorded on the “Pain Flowsheet” in the chart. Medication 
administration via PCAs was documented on both the Medication Administration Record (MAR) 
and the PCA Flowsheet.  When pain medication was administered or a non-pharmacologic 
intervention to alleviate pain had been performed (such as a heat pack), pain was reassessed 
within 60 minutes of the intervention. If the patient continued to verbalize unsatisfactory pain 
relief, the nurse intervened by either administering more pain medication based on orders from 
the physician or performing a non-pharmacologic intervention. Administration of extra doses of 
pain medication were recorded in the MAR and recorded in the PCA Flowsheet.  
   For patients who were not on PCAs, but prescribed more than one opioid, an opioid plus 
adjunct medication to achieve satisfactory pain control or escalating doses of opioids, the patient 
was placed on capnography.   Only one patient in the capnography group met this criterion 
(Appendix F).         
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Data Collection 
       The data and variables collected for this project are listed in the Data Dictionary (Appendix 
E). All data was stored in SPSS software on a password protected computer.  Each patient was 
de-identified and assigned a random participant number and demographic data of age, gender, 
diagnosis, co-morbidities, and reason for admission was collected from the patient chart. The 
standard monitoring sample from the retrospective chart review was obtained with the assistance 
of pharmacy who was able to generate a report of all patients on PCAs or receiving opioids in the 
ICU for the three months specified. Data collection for both the standard monitoring and 
capnography groups included date of data collection, assignment of participant number, age, 
gender, procedure type or reason for ICU admission, diagnosis, type of PCA or receiving high 
doses of opioids (not IV or epidural), number of and list of specific co-morbidities, adverse 
events (if any) and nursing actions taken in response to the event, and capnography monitoring 
(for the capnography group only). All data were retrieved from the medical record and the PI 
rounded in the ICU daily to see patients and have conversation with the practitioners and nurses. 
The ICU nurses and respiratory therapists use the electronic Critical Care Flowsheet to document 
care and events. The Philips monitors automatically transfer information into the critical care 
flowsheet hourly so patient measurements (including ETCO2) can be retrieved.  There was no 
missing data for this project.  
     Adverse events that occurred with the PCA and the interventions used to reverse the event 
were recorded in the medical record.  The nurses documented on all events within the Pain 
Assessment and PCA flowsheets.  
Data analysis 
CAPNOGRAPHY IMPLEMENTATION                                                                                                                    23                                                                                                              
     Data analysis included descriptive statistics of the sample and variables (see Table 1, 
Appendix F). After the descriptive statistics of the sample were completed, chi-square analyses 
were performed to evaluate the impact of capnography monitoring. The independent variable 
was capnography monitoring, and the dependent variables are adverse events defined as episodes 
of hypoxia, hypercapnia, hypotension, bradypnea, and sedation level.  Alpha was set at 0.05.  
The final sample size consisted of 20 patients: 10 in the standard monitoring group and 10 in the 
capnography group.  
Timeline 
     This project took place from June through December 2020.  Support for this project was 
obtained from nursing and medical leadership in the ICU.  Review of background of the project, 
criteria for capnography with the high risk versus low-risk criteria (Appendix G), and normal 
ETCO2 values were provided to nursing, respiratory therapists, and practitioner staff in the ICU.  
Contact information for the investigator was provided in case of questions and the PI rounded in 
the ICU at least daily Monday through Friday during the implementation period.   
Resources Needed 
   Stakeholders for this project included the ICU leadership (nursing management and attending 
physicians), ICU medical fellows, the nursing service educator for the ICU, respiratory therapists 
in the ICU, the ICU pharmacists, and the nursing staff.  Nursing, medical, and respiratory 
therapy staff provided care as is routine in the ICU except for needing to manage the 
capnography equipment and alarms.  This increased the workload of the staff due to issues with 
the nasal cannula (described in the Results section).  The educator, CNS, managers, and charge 
nurses for the ICU assisted in trouble shooting the equipment and helped identify patients for 
whom capnography would be beneficial.  
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Ethical Considerations 
     The capnography equipment is associated with minimal harm and this intervention is already 
a standard of care in the community, so no research interventions were conducted. Identifiable 
patient information was not collected for this project. The Institutional Review Board at the 
project site deemed this project as exempt from board review due to minimal risk to subjects and 
not a research intervention. 
Security 
     All patients were de-identified and assigned a random number.  All data was stored in SPSS 
on a password protected computer. 
                                                                      Results 
 
     The purpose of this project was to evaluate the effectiveness of capnography versus standard 
monitoring to decrease adverse events among patients admitted to the intensive care unit (ICU) 
who were prescribed patient-controlled analgesia (PCA) or high doses of opioids and were 
considered at high risk for respiratory depression. There were 10 patients who received 
capnography and 10 patients who received standard monitoring.  Most of the patients in both the 
capnography and standard monitoring groups were over 55 years of age and male (60%).  The 
most common diagnosis was cancer (80%).  Within the standard monitoring group half of the 
patients had at least one co-morbidity. Within the capnography group, 90% of patients had at 
least one co-morbidity.  The descriptive statistics for the patients are reported in Table 1 
(Appendix G).   
       Analysis of the data, using chi-square test of independence, showed no statistically 
significant differences in the number of adverse events between those patients who were 
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monitored with capnography and those who received standard monitoring, (X2(1, N=20) = 0.00, 
p=1.00) (Appendix H, Table 2).  Analysis of each of the aims of the study were as follows: 
1. For Aim 1, capnography monitoring was implemented between September 8, and 
December 1, 2020 for 10 ICU patients receiving intravenous, epidural PCAs or high 
doses of opioids. There were 30% of the patients on capnography who had an adverse 
event specifically, hypercapnia, hypoxia, hypotension, decreased sedation level, or 
bradypnea during the implementation timeframe (Appendix I, Table 3).    
2. For Aim 2, a retrospective chart review was conducted for June 2020 through August 
2020, and 30% of 10 ICU patients on intravenous, epidural PCAs or high doses of 
opioids who received standard monitoring had an adverse event including: Hypoxia, 
hypotension, bradypnea, or decreased sedation level (Table 3).   
3. Differences in number of episodes of adverse events between 10 ICU patients on PCAs 
or high doses of opioids monitored with capnography versus 10 patients on standard 
monitoring was compared with chi-square test of independence.  There was no statistical 
difference between the two groups, X2(1, N=20) = 0.00, p=1.00.   (Table 2). 
4. Differences in the number of episodes of hypercapnia, hypoxia, hypotension, decreased 
sedation level, bradypnea (adverse patient events) was compared according to variation in 
age, gender, diagnosis, and co-morbidities among ICU patients on PCAs or high dosages 
of opioids using crosstabs comparison and chi-square test of independence for each 
variable. Adverse events were not significantly associated with age, gender, number of 
co-morbidities, type of opioid, and diagnosis (p>0.05) (Table 4, Appendix J). However, a 
higher number of adverse events were observed in patients older than 55 years (30%), 
those on epidural opioids (25%), females (20%), and those with two or more co-
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morbidities including lung/cardiac disease and a history of >20 pack year smoking 
history (20%) (Table 4).  Additionally, the percentage of patients with the occurrence of 
different monitoring events related to blood pressure, carbon dioxide, oxygen saturation, 
respiratory rate and sedation level are presented in Table 3 (See Appendix I). 
Interestingly, the capnography monitoring group showed modest favorable trends 
compared with the standard monitoring group related to respiratory rate and sedation 
level. Specifically, there was a decrease in the percentage of patients who had a 
respiratory rate less than 12 breaths per minute in the capnography group (20%) 
compared with the standard monitoring group (30%). There was also a decrease in the 
percentage of patients who were difficult to arouse in the capnography group (0%) versus 
the standard monitoring group (10%). 
                                                            Discussion 
 
     Many randomized controlled trials have demonstrated that capnography monitoring is 
superior to monitoring with vital signs, pulse oximetry, and sedation level alone (standard 
monitoring) in detecting early respiratory depression.  Rising ETCO2 levels is a sensitive and 
specific sign of respiratory distress and occurs before changes in vital signs or decrease in 
oxygenation levels.  Based on the results of these research studies, professional and regulatory 
organizations recommend that sensitive technology be utilized as a method for detecting early 
respiratory depression. Capnography is a non-invasive, sensitive mechanism for recognizing 
changes in patient status before harm occurs.   
     The advantage of capnography monitoring is it allows nurses to perform interventions to 
reverse respiratory depression before resorting to the administration of naloxone.  The study by 
Stites, et. al., (2017) demonstrated that the number of rapid response calls (RRT) for opioid 
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induced respiratory depression in patients who received opioids through a PCA before and after 
hospital wide implementation of capnography decreased. Naloxone is not without potential for 
harm as not only does it cause a complete reversal of pain control but can cause adverse effects 
along with the reversal of the opioid. These adverse effects can include the need to re-establish 
adequate pain control and at the extreme, psychosis, arrhythmias, and cardiopulmonary arrest.  
Use of “softer” nursing interventions to gently reverse the effect of the opioid would be 
preferable to naloxone administration.  
     At issue is the type of patient who would be appropriate for capnography monitoring.  Over 
30 patient characteristics have been described within clinical trials that would warrant 
consideration for capnography.  Since it is not feasible that every patient at this institution would 
require capnography monitoring, this project attempted to narrow criteria among our population 
that would benefit from this type of intensive monitoring.  Among characteristics identified in 
the literature that were examined for the purposes of this project included patients older than 55 
years, those with multiple co-morbidities including obstructive sleep apnea, smoking history 
greater than 20 pack years and patients with a history of lung and/or cardiac disease.  More 
adverse events among these groups were observed during this project, further supporting which 
patient type should receive capnography.  
      This project evaluated if capnography monitoring improved outcomes in terms of decreasing 
adverse events among ICU patients who were receiving opioids through an epidural or 
intravenous PCA, or high doses of opioids administered via other routes.  A retrospective sample 
of patients who received standard monitoring was evaluated for adverse events and compared 
with patients who received capnography monitoring.  The sample size and descriptive 
characteristics for both groups were similar; there was no statistically significant difference in 
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the number of adverse events for patients receiving capnography versus standard monitoring.  In 
addition, there were no significant differences in the number of adverse events with respect to 
age, gender, opioid type, number of co-morbidities, and diagnosis. Although not statistically 
significant, patients older than 55 years of age, females, those receiving epidural patient-
controlled analgesia, and those with two or more co-morbidities plus a history of lung or cardiac 
disease, obstructive sleep apnea, or greater than a 20-pack year history of smoking, had more 
observable adverse events. These findings indicate patient characteristics that may be associated 
with a higher risk for respiratory depression. Implementing capnography monitoring among 
patients with these identified risk factors may allow for early intervention to prevent 
complications and adverse events.   
     Limitations of this study included the impact of the COVID-19 pandemic, the setting in which 
this project was implemented (ICU), eligibility criteria for patient inclusion in the project, and 
the nasal cannula equipment used for the capnography.  The impact of the pandemic resulted in a 
small sample size for both the standard monitoring and capnography implementation groups.  
Patients diagnosed with COVID-19 admitted to the ICU were critically ill and therefore did not 
meet eligibility criteria for inclusion in this project.   
     Secondly, all patients enrolled into the study were patients under ICU level care.  Patient 
observation in an ICU is closely monitored as all patients were connected to monitoring 
equipment such as continuous vital sign monitoring.  Nursing care was also provided under a 
one-to-one ratio so that a slight change in patient condition would be detected before the patient 
became hypercapnic.  Therefore, hypercapnic episodes had been low throughout this study.  
However, capnography monitoring among the capnography group allowed for earlier detection 
of hypotension, hypoxia, and decreased sedation (Table 3).  None of the patients in the 
CAPNOGRAPHY IMPLEMENTATION                                                                                                                    29                                                                                                              
capnography group required naloxone; instead, nursing interventions (stopping or decreasing the 
PCA dose and re-positioning) reversed the effects of the opioids while maintaining adequate pain 
control.  As the intent of this project is to eventually implement capnography monitoring on the 
non-ICU medical units, and nursing care is not provided one-to-one for the most part, the true 
benefit of capnography monitoring is yet to be determined. 
     Eligibility for inclusion into the study may also have impacted results.  As the ICU also 
admits children (defined as younger than 18 years), the nursing and medical staff observed that 
some teenagers may have benefited from capnography monitoring. These teenagers (ranging in 
age from 15-17 years) had increased confusion, somnolence, hypoxia, or hypotension from the 
opioids (epidural and intravenous).  Inclusion of adolescents into the project may have 
demonstrated that capnography would benefit this population too.  
     The last observation was difficulty with the nasal cannula equipment that was used for 
ETCO2 monitoring.  Nurses and respiratory therapists observed that as the nasal cannula became 
moist with patient respiration, the cannula stopped detecting accurate ETCO2.  The readings on 
the modules displayed false readings of hypocapnia.  The nasal cannula on patients needed 
changing every eight to ten hours to continue to obtain accurate measurements.  This resulted in 
anecdotal decreased nurse satisfaction and could have a potential  impact on implementation of 
this project for the rest of the hospital.  
     For the institution in which this project was conducted, the recommendation is that 
capnography monitoring should be used in patients receiving epidural or IV PCAs until stable 
doses are reached for satisfactory pain control and the patient has been without hypotension, 
hypoxia, decreased sedation level, bradypnea, or hypercapnia for at least 24 hours.  Patients who 
are receiving frequent, escalating doses of opioids, not on PCAs, can also benefit from 
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capnography.  Patient types who would most benefit from initial capnography include patients 
older than 55 years, those on epidural opioids, females, and those with two or more co-
morbidities including obstructive sleep apnea, lung/cardiac disease, and a history of >20 pack 
year smoking history. Although not a part of the sample for this project, teenagers aged 14-17 
years may also benefit. 
                               Plans for Sustainability and Future Scholarship 
      Vital sign machinery with capnography technology has been purchased for this institution.  
There will now be the opportunity to perform capnography monitoring outside of the ICU.  
Discussion among the Pain and Palliative Service, medical team and nursing leadership is 
underway for the employment of capnography monitoring among patients who are considered 
high risk for respiratory depression. Policies and procedures will need to be created.  Nursing 
and physician education will need to be developed.  Integrating capnography monitoring as a 
standard of practice will provide sustainability to this initiative. 
     Future directions with capnography monitoring at this institution include further defining 
patients, including teenagers, who would profit from capnography.  In addition, determining if 
added equipment purchases are needed will require consideration.  Future scholarship 
opportunities include ongoing assessment of the benefit of capnography through auditing of 
naloxone use in the institution, impact of capnography on alarm fatigue among nurses, and if 
capnography results in improved patient satisfaction with pain management.                                                      
                                                                 Conclusion 
     Randomized controlled trials have demonstrated that capnography monitoring in patients 
receiving opioids can be beneficial in detecting early respiratory compromise before adverse 
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outcomes occur.  This project was limited by the small sample size and ICU level care patients 
received.  However, observable results from this project suggested that capnography monitoring 
may be most useful in patients 55 or older, those receiving epidural opioids, and those with 
multiple co-morbidities including smoking history, obstructive sleep apnea, and lung and/or 
cardiac disease.  Teenagers may also benefit from capnography based on anecdotal observation. 
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                                                                 Appendix A 
SWOT Analysis 
 Helpful 
To achieving the objective 
Harmful 































 Stakeholder involvement 
 Commitment of leadership in 
all departments 
 A commitment to providing 
excellent clinical care 
 Employee engagement 
 Nursing shared governance 
 Strong nursing education 
department 
 Strong CNS group  
 New vital sign equipment 
purchase 
Weaknesses 
 Budgetary constraints 
 Outdated clinical knowledge due to 
“institutialization” of researchers.  
 No central telemetry monitoring on 
































 Accreditation and survey by 
outside organizations 
concerned with patient safety 
 Wanting to bring NIH up to 
highest clinical practice 
standards 
 Influx of new personnel who 
have practiced in the 
community and are 
knowledgeable about best 
practices 
 Defining a high-risk patient 
based on research 
Threats 
 Unwillingness to change culture in 
some areas of the NIH 
 Cybersecurity concerns about the 
capnographic equipment  
 Consensus on the clear definition of 
who a high-risk patient would be who 
would require capnography 
 Attitude by some that research 
outweighs clinical care 
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                                                                                     Appendix B 
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Intervention Group: 
Standard of care (as 
above) plus continuous 
end tidal CO2 
monitoring which was 
recorded every 5 
minutes 
 





outcomes in this 
trial 
Conclusion:  Use 
of capnography 
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Standard monitoring as 
above but MDs could 
not visualize the 
capnometer  
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-opioid 
dependence 
8. In Weingarten 
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control group vs 
experimental 
group (0 v 10%) 
Recovery time 
shorter in the 
control group vs 
experimental 
group (9.9 min. 












assessed due to 
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Kochhar, G., 
Albedawi, M., 
Kirsh, B., Rizk, 
M., Putka, 
B……Vargo, J.  
(2016).   
Randomized 
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visualized, and findings 




to provider  
EGD Group Total: 208 
Control: 101 





Blinded:  114 
 
 No statistical 
difference in rates 
of hypoxemia 
detection between 
the groups for 
both arms 
 






blinded and open 
capnography 
arms for EGD 
(54.1% vs. 49.5;  
P =0.5) or 
colonoscopy 





















Patients on PCA 
Capnography 
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and Ruyter, D. 



























reduction in RR 
calls associated 
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Records identified through 
PubMed, CINAHL, Google Scholar, 




























Additional records identified 
through other sources 
(n = 0) 






Full-text articles assessed 
for eligibility 
(n =37) 
Full-text articles excluded, 
with reasons 
(n =29) 
 Systematic reviews 
(n=13) 
 Study described 
operating room use 
or resuscitative use 
(n=10) 
 Study in French 
(n=1) 
 Study described use 
of ETCO2 for 
endotracheal tube 
placement (n=1) 




 Study described use 
in children during 
tonsillectomy (n=1) 
 Pediatric studies 
(n=2) 
 
Studies included in 
quantitative synthesis  
(n = 8) 
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                                                            Appendix E 
Data Dictionary 
Data Element Data 
Label 
Data Type Definition/Purpose 
 
Data Values & Coding 
Patient 
Identifier 
ID Numeric Unique identifier 
assigned by PI 
Numeric 
Age in years Age  Categorical Age of patient 55 years 
or older OR less than 
55 years  
0= 55 or > 
1=< 55 






categorical Diagnosis of patient 







COM Categorical Number of co-
morbidities 
0=no co-morbidities 
1=1 co-morbidity or smoker 
(>20pack years), lung/cardiac 
dz., and/or OSA 









2=high dose not IV or epidural 




Hypotension HTN Categorical Blood pressure <90/60 0=no hypotension 
1=hypotensive 
Hypercapnia HYC Categorical ETCO2 >45mmHg 0=no hypercapnia 
1=hypercapnic 
Hypoxia HYP Categorical Pulse oximetry <90% 0=no hypoxia 
1=hypoxic 
Sedation level SED Continuous Level of sedation while 
on PCA 
0=alert/drowsy/easily aroused 
1=sleeping/difficult to arouse 
2=confused/hallucinating 
3=unable to arouse 






AE Categorical Type of AE that is 









NA Categorical Type of nursing actions: 
           0. none 
1. Hold PCA or 
opioids 
2. Repositioning 







1=Hold PCA or opioids 
2=Repositioning 
3=PCA settings or narcotics 
dosing decreased 
4=Rescue, including naloxone 
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Patient admitted with PCA or requires 
frequent, escalating doses of opioids 
for pain control AND is considered 
high-risk for respiratory depression 
No 
Monitoring as per policy:  
 Vitals hourly 
 Sedation hourly 
 Pain assessment as 
per Nursing Policy 
(at least every 4 
hours) 
Continue to monitor 
for capnography need 
Yes High-risk criteria: 
1.  PCA 
2. Use of two or more opioids 
or adjunct agents 
simultaneously  
3. Frequent escalating doses 
of opioids (patients not on 
PCAs)  
4. Concern by medical or 
nursing staff that patient at 
risk for respiratory 
depression  
 
Place patient on capnography 
 
Ongoing data collection for 
determination of accuracy of criteria 
defining high-risk 
 
Document assessment in 
EMR  
Hourly ETCO2 reading 
documented in EMR (if 
applicable) 
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Appendix G 
Table 1:  Descriptive Characteristics of the Patients 
Characteristics Standard Monitoring Capnography Monitoring 
Age 58.1 (+ 18) 59.7 (+ 15) 
Gender   
     Male 60% 50% 
     Female 40% 50% 
Primary Diagnosis   
    Cancer 80% 70% 
    Immunodeficiency/ 
    transplant 
10% 20% 
    Other 10% 10% 
Number of co-morbidities 
(COM) 
  
      None 50% 10% 
     One COM or smoker,   
     lung/cardiac disease, OSA 
10% 40% 
     Two or more COM plus  
     Above 
40% 50% 
Opioid Type   
    Epidural PCA 40% 70% 
   IV PCA 60% 20% 
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                                                                                      Appendix H 
Table 2:  Comparison of Capnography Monitoring and Number of Adverse Patient Events 
Capnography             N              Adverse 
Events 
                                                        N           % 
             Chi Square Statistics 
              df        N     p        X2 
 
No capnography         10                 3            30%               1       20   1.00      0.00 
Capnography              10                 3            30% 
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                                                                               Appendix I 
Table 3: Percentage of patients with monitoring events 







Monitoring Event Standard Monitoring Capnography Monitoring 
Systolic BP<90/60   
       Yes                      10% 20% 
      No                      90% 80% 
ETCO2>45   
     Yes N/A 30% 
    No N/A 70% 
SpO2<90   
    Yes 10% 30% 
    No 90% 70% 
Respiratory Rate   
   12-20 breaths per minute 70% 80% 
<12 breaths per minute 30% 20% 
Sedation Level   
    Alert/oriented 90% 80% 
   Difficult to arouse 10% 0% 
   Confused hallucinating 0% 10% 
   Unable to arouse 0% 10% 
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                                                                            Appendix J 
Table 4:  Comparison of Adverse Events with Age, Gender, Number of Co-morbidities, Opioid Type and 
Diagnosis  
N=20 
       
Variable  Adverse Event 
(percentage) 
Df p Chi-Square 
Statistic (X2) 
Age     
    55 or older 30% 1 .091 2.857 
    < 55 0%    
Gender     
  Male 10% 1 .202 1.626 
  Female 20%    
Number of Co-morbidities 
(COM) 
    
   None 5% 2 .440 1.640 
 One COM or > 20py 
smoking or   lung/cardiac disease 
and/or OSA 
5%    
Two COM + above 20%    
Opioid Type     
   Epidural 25% 2 .241 2.846 
   IV PCA 5%    
  High dose not epidural or IV 
PCA 
0%    
 
Diagnosis 
    
 Cancer 30% 2 .240 2.857 
 Immunodeficiency/transplant 0%    
Other 0%    
                                                  
 
 
                                                            
 
